32963904|t|Mirtazapine Creating "Miracles" in Psychotic Depression With Catatonia.
32963904|a|Catatonia is commonly seen in patients with mood disorders and schizophrenia. The treatment of catatonia requires immediate attention as delayed care resulted in malignant catatonia. The first-line treatment for catatonia is benzodiazepines (BZDs) with rapid improvement. First-generation antipsychotics (FGAs) increase the risk of neuroleptic malignant syndrome and so are avoided in catatonic patients. Second-generation antipsychotics (SGAs) are recommended for treatment in catatonic patients. Treatment for catatonia due to depression includes serotonin reuptake inhibitors (SSRIs). When an individual manifests catatonia during an episode of depression with psychotic features, it is valid to administer both SSRIs and SGAs. Relatively very few studies have examined the use of atypical antidepressants, such as mirtazapine, and so we present a case of catatonia due to severe depression with psychotic features that improved significantly after the introduction of mirtazapine. Despite the beneficial effects of mirtazapine in psychotic depression and catatonia, it is underutilized due to the scarcity of literature. We recommend future clinical studies to evaluate mirtazapine's "miracle" effects, particularly in such patients presenting with psychotic depression and catatonia.
32963904	0	11	Mirtazapine	Chemical	MESH:D000078785
32963904	35	55	Psychotic Depression	Disease	MESH:D000341
32963904	61	70	Catatonia	Disease	MESH:D002389
32963904	72	81	Catatonia	Disease	MESH:D002389
32963904	102	110	patients	Species	9606
32963904	116	130	mood disorders	Disease	MESH:D019964
32963904	135	148	schizophrenia	Disease	MESH:D012559
32963904	167	176	catatonia	Disease	MESH:D002389
32963904	234	253	malignant catatonia	Disease	MESH:D002389
32963904	284	293	catatonia	Disease	MESH:D002389
32963904	297	312	benzodiazepines	Chemical	MESH:D001569
32963904	314	318	BZDs	Chemical	MESH:D001569
32963904	377	381	FGAs	Chemical	-
32963904	404	434	neuroleptic malignant syndrome	Disease	MESH:D009459
32963904	457	466	catatonic	Disease	MESH:D012560
32963904	467	475	patients	Species	9606
32963904	511	515	SGAs	Chemical	-
32963904	550	559	catatonic	Disease	MESH:D012560
32963904	560	568	patients	Species	9606
32963904	584	593	catatonia	Disease	MESH:D002389
32963904	601	611	depression	Disease	MESH:D003866
32963904	689	698	catatonia	Disease	MESH:D002389
32963904	720	730	depression	Disease	MESH:D003866
32963904	736	745	psychotic	Disease	MESH:D011618
32963904	797	801	SGAs	Chemical	-
32963904	890	901	mirtazapine	Chemical	MESH:D000078785
32963904	931	940	catatonia	Disease	MESH:D002389
32963904	955	965	depression	Disease	MESH:D003866
32963904	971	980	psychotic	Disease	MESH:D011618
32963904	1044	1055	mirtazapine	Chemical	MESH:D000078785
32963904	1091	1102	mirtazapine	Chemical	MESH:D000078785
32963904	1106	1126	psychotic depression	Disease	MESH:D000341
32963904	1131	1140	catatonia	Disease	MESH:D002389
32963904	1246	1257	mirtazapine	Chemical	MESH:D000078785
32963904	1300	1308	patients	Species	9606
32963904	1325	1345	psychotic depression	Disease	MESH:D000341
32963904	1350	1359	catatonia	Disease	MESH:D002389
32963904	Negative_Correlation	MESH:D000078785	MESH:D002389
32963904	Negative_Correlation	MESH:D000078785	MESH:D000341
32963904	Negative_Correlation	MESH:D000078785	MESH:D003866
32963904	Negative_Correlation	MESH:D001569	MESH:D002389
32963904	Negative_Correlation	MESH:D000078785	MESH:D011618

